McIntyre CA, Grimont A, Park J, Meng Y, Sisso WJ, Seier K, Jang GHo, Walch H, Aveson VG, Falvo DJ et al..  2024.  Distinct clinical outcomes and biological features of specific KRAS mutants in human pancreatic cancer.. Cancer Cell. 42(9):1614-1629.e5.

Gartrell RD, Enzler T, Kim PS, Fullerton BT, Fazlollahi L, Chen AX, Minns HE, Perni S, Weisberg SP, Rizk EM et al..  2022.  Neoadjuvant chemoradiation alters the immune microenvironment in pancreatic ductal adenocarcinoma.. Oncoimmunology. 11(1):2066767.

Rodić N, Steranka JP, Makohon-Moore A, Moyer A, Shen P, Sharma R, Kohutek ZA, Huang CRan, Ahn D, Mita P et al..  2015.  Retrotransposon insertions in the clonal evolution of pancreatic ductal adenocarcinoma.. Nat Med. 21(9):1060-4.